Is mTOR inhibition a systemic treatment for tuberous sclerosis?

Tuberous sclerosis complex (TSC) is a genetic multisystem disorder characterized by the development of hamartomas in several organs. Mutations in the TSC1 and TSC2 tumor suppressor genes determin overactivation of the mammalian target of rapamycin (mTOR) signaling pathway and subsequent abnormalitie...

Descripción completa

Detalles Bibliográficos
Autores principales: Moavero, Romina, Coniglio, Antonella, Garaci, Francesco, Curatolo, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848592/
https://www.ncbi.nlm.nih.gov/pubmed/24044547
http://dx.doi.org/10.1186/1824-7288-39-57

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848592/
https://www.ncbi.nlm.nih.gov/pubmed/24044547
http://dx.doi.org/10.1186/1824-7288-39-57

Ejemplares similares